Restenosis Therapy Using Mesenchymal Stem Cells
    81.
    发明申请
    Restenosis Therapy Using Mesenchymal Stem Cells 审中-公开
    使用间充质干细胞进行再狭窄治疗

    公开(公告)号:US20070219526A1

    公开(公告)日:2007-09-20

    申请号:US11749522

    申请日:2007-05-16

    Applicant: Toby Freyman

    Inventor: Toby Freyman

    CPC classification number: C12N5/0663 A61K38/28 A61K2035/124

    Abstract: The present invention relates to methods for treating restenosis using mesenchymal stem cells, and in particular to treating restenosis following vascular surgery (e.g., angioplasty, stent implantation, rotoblation, atheroectomy, thrombectomy, or grafting).

    Abstract translation: 本发明涉及使用间充质干细胞治疗再狭窄的方法,特别涉及血管手术(例如,血管成形术,支架植入,旋转索,动脉粥样硬化切除术,血栓切除术或移植)后的再狭窄治疗。

    Valve treatment catheter and methods
    82.
    发明授权
    Valve treatment catheter and methods 有权
    阀门治疗导管及方法

    公开(公告)号:US07244242B2

    公开(公告)日:2007-07-17

    申请号:US11086867

    申请日:2005-03-22

    Applicant: Toby Freyman

    Inventor: Toby Freyman

    Abstract: The invention provides a catheter for insertion into a biological passage which contains a first flowing fluid, the catheter including a tubular member having a proximal end and a distal end; a fluid delivery lumen contained within the tubular member; an inflatable balloon assembly disposed at the distal end of the tubular member, the balloon assembly including an inflatable balloon member having an uninflated state and an inflated state, the balloon assembly including apertures in communication with the fluid delivery lumen; an inflation lumen in communication with the balloon member; and a valve contained within the inflatable balloon assembly. The inflatable balloon is assembly configured such that when the balloon member is in the inflated state: (i) sections of the balloon member contact the biological passage defining at least one containment pocket; (ii) the apertures are disposed in the containment pocket, (iii) a flow lumen is defined through the balloon member to allow the first fluid to flow through the balloon member; and (iv) the valve functions to allow the first flowing fluid to flow through the flow lumen in a physiologic direction, while blocking backflow of the first fluid through the flow lumen.

    Abstract translation: 本发明提供一种用于插入生物通道中的导管,其包含第一流动流体,该导管包括具有近端和远端的管状构件; 容纳在管状构件内的流体输送腔; 设置在所述管状构件的远端的可充气球囊组件,所述球囊组件包括具有未膨胀状态和膨胀状态的可膨胀球囊构件,所述球囊组件包括与所述流体输送腔连通的孔; 与球囊构件连通的通气腔; 以及包含在可充气球囊组件内的阀。 充气气囊被组装成使得当球囊构件处于充气状态时:(i)球囊构件的部分接触限定至少一个容纳口袋的生物通道; (ii)孔口设置在容纳袋中,(iii)流动腔通过球囊构件限定,以允许第一流体流过球囊构件; 和(iv)所述阀的功能是允许所述第一流动流体在生理方向上流过所述流动腔,同时阻止所述第一流体通过所述流动腔的回流。

    Selected cell delivery for heart failure
    84.
    发明授权
    Selected cell delivery for heart failure 有权
    选择细胞转运心脏衰竭

    公开(公告)号:US07097833B2

    公开(公告)日:2006-08-29

    申请号:US10198101

    申请日:2002-07-19

    Applicant: Toby Freyman

    Inventor: Toby Freyman

    CPC classification number: A61K35/28 A61K35/15

    Abstract: This invention provides methods of increasing blood flow to tissue in a subject in need thereof, methods of regenerating tissue in a subject, methods of treating diseased tissue in a subject, methods of forming new blood vessels in tissue and new tissue, such as myocardial tissue, in a subject in need thereof, methods of increasing angiogenesis in diseased tissue in a subject, and methods of preventing heart failure in a subject, which methods comprise: a) isolating autologous mononuclear cells from the subject; b) selecting from the isolated autologous mononuclear cells of step (a) lineage negative (Lin−) mononuclear cells; and c) transplanting locally into or adjacent to the tissue an effective amount of the Lin− autologous mononuclear cells, resulting in formation of new blood vessels in the tissue and formation of new tissue. Additional methods provided for such uses further select from the isolated autologous mononuclear cells of step (a) lineage negative (Lin−) mononuclear cells a subset of Lin− mononuclear side population (SP) cells and transplant locally into or adjacent to the tissue an effective amount of the Lin− SP cells. In other aspects, methods using tissue other than mononuclear cells for these uses are provided, which comprise (a) obtaining a cell suspension from the tissue or a second tissue of the subject; (b) selecting from the cell suspension step (a) side population (SP) cells; and (c) transplanting locally into or adjacent to the tissue an effective amount of the SP cells, resulting in formation of new blood vessels in the tissue and formation of new tissue.

    Abstract translation: 本发明提供了在有需要的受试者中增加血液流向组织的方法,在受试者中再生组织的方法,治疗受试者中的患病组织的方法,在组织中形成新血管的方法和新组织如心肌组织 在有需要的受试者中,增加受试者患病组织中血管生成的方法,以及预防受试者心脏衰竭的方法,所述方法包括:a)从受试者中分离自体单核细胞; b)从步骤(a)谱系阴性(Lin - >)单核细胞的分离的自体单核细胞中选择; 和c)在组织中或附近移植有效量的自身单核细胞,导致在组织中形成新血管并形成新组织。 为这种用途提供的另外的方法进一步从步骤(a)分离的自体单核细胞中选择一个亚单位的单核细胞侧群体(LIN SP)细胞,并将其局部移植到组织中或与组织相邻的有效量的Lin SP细胞。 在其他方面,提供了使用除了单核细胞以外的组织用于这些用途的方法,其包括(a)从受试者的组织或第二组织获得细胞悬浮液; (b)从细胞悬浮液步骤(a)选择侧群体(SP)细胞; 和(c)在组织中或附近移植有效量的SP细胞,导致在组织中形成新血管并形成新组织。

    Valve treatment catheter and methods

    公开(公告)号:US20050209580A1

    公开(公告)日:2005-09-22

    申请号:US11086867

    申请日:2005-03-22

    Applicant: Toby Freyman

    Inventor: Toby Freyman

    Abstract: The invention provides a catheter for insertion into a biological passage which contains a first flowing fluid, the catheter including a tubular member having a proximal end and a distal end; a fluid delivery lumen contained within the tubular member; an inflatable balloon assembly disposed at the distal end of the tubular member, the balloon assembly including an inflatable balloon member having an uninflated state and an inflated state, the balloon assembly including apertures in communication with the fluid delivery lumen; an inflation lumen in communication with the balloon member; and a valve contained within the inflatable balloon assembly. The inflatable balloon is assembly configured such that when the balloon member is in the inflated state: (i) sections of the balloon member contact the biological passage defining at least one containment pocket; (ii) the apertures are disposed in the containment pocket, (iii) a flow lumen is defined through the balloon member to allow the first fluid to flow through the balloon member; and (iv) the valve functions to allow the first flowing fluid to flow through the flow lumen in a physiologic direction, while blocking backflow of the first fluid through the flow lumen.

    Decellularized bone marrow extracellular matrix
    89.
    发明授权
    Decellularized bone marrow extracellular matrix 有权
    脱细胞骨髓细胞外基质

    公开(公告)号:US08790920B2

    公开(公告)日:2014-07-29

    申请号:US12021625

    申请日:2008-01-29

    Applicant: Toby Freyman

    Inventor: Toby Freyman

    Abstract: The invention is directed to compositions comprising decellularized bone marrow extracellular matrix and uses thereof. Methods for repairing or regenerating defective, diseased, damaged or ischemic tissues or organs in a subject, preferably a human, using the decellularized bone marrow extracellular matrix of the invention are also provided. The invention is further directed to a medical device, preferably a stent or an artificial heart, and biocompatible materials, preferably a tissue regeneration scaffold, comprising decellularized bone marrow extracellular matrix for implantation into a subject.

    Abstract translation: 本发明涉及包含脱细胞的骨髓细胞外基质及其用途的组合物。 还提供了使用本发明的脱细胞化骨髓细胞外基质修复或再生受治疗者,优选人的有缺陷,患病,损伤或缺血组织或器官的方法。 本发明进一步涉及医疗装置,优选支架或人造心脏,以及生物相容性材料,优选组织再生支架,其包括用于植入受试者的脱细胞骨髓细胞外基质。

Patent Agency Ranking